SUNY Downstate Medical Center

12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation (2020) Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp AS, Schmieder R, Wang Y, et al. Journal article Confounding Factors in Renal Denervation Trials Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for Hypertension (2020) Kandzari DE, Mahfoud F, Bhatt DL, Boehm M, Weber MA, Townsend RR, Hettrick DA, et al. Journal article, Review article Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial (2020) Mahfoud F, Townsend R, Kandzari D, Kario K, Schmieder R, Tsioufis K, Boehm M, et al. Conference contribution Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies (2020) Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Böhm M, et al. Journal article Alcohol-mediated renal sympathetic neurolysis for the treatment of hypertension: The Peregrine™ infusion catheter (2020) Bertog S, Sharma A, Mahfoud F, Pathak A, Schmieder R, Sievert K, Papademetriou V, et al. Journal article, Review article Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial (2020) Kario K, Weber MA, Böhm M, Townsend RR, Mahfoud F, Schmieder R, Tsioufis K, et al. Journal article Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (Clinical Research in Cardiology, (2020), 109, 3, (289-302), 10.1007/s00392-020-01595-z) (2020) Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder R, et al. Journal article, Erratum Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (2020) Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder R, et al. Journal article Implementation of Bayesian Study Design in the SPYRAL HTN-OFF MED Pivotal Trial (2019) Boehm M, Townsend R, Weber M, Kandzari D, Mahfoud F, Kario K, Schmieder R, et al. Conference contribution Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy (2019) Kario K, Weber MA, Mahfoud F, Kandzari DE, Schmieder R, Kirtane AJ, Boehm M, et al. Journal article, Review article